Treace Medical Concepts, Inc. has a 1-year low of $3.92 and a 1-year high of $15.98. The company has a current ratio of 4.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.51.

Quite a few insiders have dramatically grown their holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) over the past 12 months. An insider's optimism about the company's prospects is a ...

Quite a few insiders have dramatically grown their holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) over the past 12 months. An insider's optimism about the company's prospects is a positive ...

announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation ...

Treace Medical (TASE:PMCN) Concepts (TMCI), a company specializing in foot and ankle orthopedics, reported an 11% increase in third-quarter revenue, amounting to $45.1 million, ...

Investing.com - Treace Medical Concepts (NASDAQ: TMCI) reported third quarter EPS of $-0.28, $0.02 worse than the analyst estimate of $-0.26. Revenue for the quarter came in at ...

A promised cap on overdraft fees and a ban on including medical debt on credit reports ... The Consumer Financial Protection Bureau, a federal agency designed to prevent another financial crisis ...

The U.S. Food & Drug Administration (FDA) advises dressing babies in clothing made from tightly woven, lightweight fabrics for sun protection ... protective clothing. Medical News Today has ...

Tissue engineering is a set of methods that can replace or repair damaged or diseased tissues with natural, synthetic, or semisynthetic tissue mimics. These mimics can either be fully functional ...

Doctors and their patients discuss the range of services that Duke Cancer Institute provides to teens and younger adults with a history of cancer. Beyond Cancer: Mental Health and Therapy Duke ...